AdCure Bio. LLC Email Format
Biotechnology ResearchGeorgia, United States2-10 Employees
AdCure Bio is a biotechnology company advancing cancer therapies at the pre-clinical stage. It concentrates on viro-immunotherapy, developing immunostimulatory oncolytic viruses intended to attack solid tumors. The aim is to harness viruses that can both kill cancer cells and stimulate the body's immune response while prioritizing safety. The focus is on providing new therapeutic options for patients with late-stage or widely disseminated cancers that have not responded to immunotherapy, chemotherapy, or other existing treatments. Based in Atlanta, Georgia, the company operates with a small team in the biotechnology research sector. It positions itself in the niche of cancer viro-immunotherapy, seeking to complement or extend current treatments for difficult-to-treat solid tumors.